A Randomized Comparison of Transobturator Tape With the Plication of Urethral Ligaments in the Treatment of Stress Urinary Incontinence
added
1 other identifier
interventional
108
1 country
1
Brief Summary
The goal of this clinical trial is to compare the efficacy of transobturator tape (TOT) operation and urethral ligament plication operation in stress incontinence patients. The main question:
- Which operation is more effective in treatment of stress incontinence?
- Which operation has less complication and risks? Participants will be followed about 5 days, 2.5 months, 6 months and 1 year after the operation and asked about the continence status and complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2024
CompletedFirst Submitted
Initial submission to the registry
January 12, 2024
CompletedFirst Posted
Study publicly available on registry
January 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedApril 3, 2025
January 1, 2024
1.1 years
January 12, 2024
March 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Subjective finding of no urinary incontinence
The patient has no urinary incontinence and a significant decrease in the UDI-6 score.
After the first day of the operation day and all of the follow-up (postoperative 5th day, 2.5 th month, 6th month and first year)
Objective finding of no urinary incontinence
Tap test negativity (if the patient's bladder is filled with 300cc physiological saline and the patient is made to cough and no urine leakage is observed, it is considered negative)
After the first day of the operation day and all of the follow-up(postoperative 5th day, 2.5 th month, 6th month and first year)
Secondary Outcomes (1)
complications
postoperative 5th day, 2.5 th month, 6th month and first year
Study Arms (2)
transobturator tape operation group
ACTIVE COMPARATORPatients who are decided to undergo surgery due to stress urinary incontinence are the group who will undergo TOT surgery through a lottery system where the computer program will decide on the surgeon who will perform the surgery, without being told which surgery they will have (both surgeries will be performed through the mid-urethral approach and the patient will not be told whether mesh is used or not).
urethral ligament plication group
ACTIVE COMPARATORPatients who are decided to undergo surgery due to stress urinary incontinence are the group who will undergo urethral ligament plication surgery through a lottery system where the computer program will decide on the surgeon who will perform the surgery, without being told which surgery they will have (both surgeries will be performed through the mid-urethral approach and the patient will not be told whether mesh is used or not).
Interventions
TOT surgery: With an 18 French Foley urinary catheter, the sling passes through the skin in the groin, the obturator foramen, the back of the adductor longus tendon, and the midurethral vaginal incision; extends 1 cm below the midpoint of the urethra, the tape is held in place without sutures by its interface with the patient's tissue. After the mesh is placed, the incision in the suburethral midline is closed.
Urethral ligament plication: With an 18 French Foley urinary catheter, a vertical incision of approximately 3 cm is made in the anterior-lateral wall sulcus of the vagina on the right and left lines, 2 cm laterally from the midline, with the urethral meatus remaining in the midline, and external urethral ligaments on both sides inferolateral to the urethra, sutured in the midline by using 2-0 or 3-0 polyester sutures on both sides separately. The incised anterior vaginal tissue is closed one by one with 2-0 rapid Vicryl.
Eligibility Criteria
You may qualify if:
- Being 18 years or older
- Presence of stress urinary incontinence symptoms
- Agreeing to have surgery
You may not qualify if:
- Pregnancy
- Being under 18 years of age
- Suspicion of malignancy
- History of previous mid-urethral sling or urinary incontinence surgery
- Being diagnosed with intrinsic sphincter (urethral) insufficiency
- Urinary incontinence due to neurological bladder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alev Esercanlead
Study Sites (1)
Sanliurfa Education and Research Hospital
Sanliurfa, 63250, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Peter Emanuel Petros, Prof.
retired
- PRINCIPAL INVESTIGATOR
Alev Esercan, MD
Sanliurfa Education and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Patients who are decided to have surgery due to stress urinary incontinence will undergo TOT surgery and urethral plication surgery, without being told which surgery they will have (both surgeries will be performed with the mid-urethral approach and the patient will not be told whether mesh is used or not), with a draw system in which the computer program will decide on the surgeon who will perform the surgery. The surgeon will always be the same person (Esercan A), and on the morning of the surgery, he will be told about the surgery he will perform and will be asked not to share it with the patient. At the end of the 5th day, 2.5 months, 6 months and 1 year after the surgery, patients will be called for a check-up and examined by the same doctor, different from the doctors who performed the surgery and wrote the publication.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Obstetrics and Gynecologist, MD
Study Record Dates
First Submitted
January 12, 2024
First Posted
January 30, 2024
Study Start
January 2, 2024
Primary Completion
February 1, 2025
Study Completion
March 1, 2025
Last Updated
April 3, 2025
Record last verified: 2024-01